1.

Etude pathologique et écotoxicologique des oiseaux et des mammifères marins dans la Mer du Nord et les régions avoisinantes. Rapport final d'activité: partim anatomie pathologique...

2.

Etude pathologique et écotoxicologique des oiseaux et des mammifères marins dans la Mer du Nord et les régions avoisinantes. Rapport final d'activité: partim anatomie pathologique...

1.

Ecotoxicological and pathological studies of common guillemots Uria aalge beached on the Belgian coast during six successive wintering periods (1989-90 to 1994-95)

2.

Ecotoxicological and pathological studies of common guillemots Uria aalge beached on the Belgian coast during six successive wintering periods (1989-90 to 1994-95)

3.

Ecotoxicological and pathological studies of common guillemots Uria aalge beached on the Belgian coast during six successive wintering periods (1989-90 to 1994-95)

4.

Ecotoxicological and pathological studies of common guillemots Uria aalge beached on the Belgian coast during six successive wintering periods (1989-90 to 1994-95)

5.

Ecotoxicological and pathological studies of common guillemots Uria aalge beached on the Belgian coast during six successive wintering periods (1989-90 to 1994-95)

1.

Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.

2.

Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.

1.

Quality of pathology reporting and adherence to guidelines in rectal neuroendocrine neoplasms: a Belgian national study.

2.

Quality of pathology reporting and adherence to guidelines in rectal neuroendocrine neoplasms: a Belgian national study.

3.

Quality of pathology reporting and adherence to guidelines in rectal neuroendocrine neoplasms: a Belgian national study.

4.

Quality of pathology reporting and adherence to guidelines in rectal neuroendocrine neoplasms: a Belgian national study.

5.

Quality of pathology reporting and adherence to guidelines in rectal neuroendocrine neoplasms: a Belgian national study.

6.

Quality of pathology reporting and adherence to guidelines in rectal neuroendocrine neoplasms: a Belgian national study.

7.

Quality of pathology reporting and adherence to guidelines in rectal neuroendocrine neoplasms: a Belgian national study.

8.

Quality of pathology reporting and adherence to guidelines in rectal neuroendocrine neoplasms: a Belgian national study.

9.

Quality of pathology reporting and adherence to guidelines in rectal neuroendocrine neoplasms: a Belgian national study.

1.

Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions.

2.

Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions.

3.

Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions.

4.

Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions.

5.

Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions.

6.

Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions.

7.

Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions.

8.

Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions.

9.

Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions.

1.

Downward spirals to vulnerability

2.

Downward spirals to vulnerability

1.

Three-dimensional Courses of Zygomaticofacial and Zygomaticotemporal Canals Using Micro-computed Tomography in Korean

2.

Three-dimensional Courses of Zygomaticofacial and Zygomaticotemporal Canals Using Micro-computed Tomography in Korean

1.

The impact of the COVID-19 pandemic on the social work client base

2.

The impact of the COVID-19 pandemic on the social work client base

1.

Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study

2.

Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study

3.

Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study

4.

Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study

5.

Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study

1.

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Onc...

2.

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Onc...

3.

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Onc...

4.

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Onc...

5.

Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Onc...